Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
LIGAND PHARMACEUTICALS INCORPORATED <LGND.O>: STIFEL RAISES TARGET PRICE TO $350 FROM $332

LIGAND PHARMACEUTICALS INCORPORATED <LGND.O>: STIFEL RAISES TARGET PRICE TO $350 FROM $332

ReutersReuters2026/10/30 11:20
By:Reuters
LIGAND PHARMACEUTICALS INCORPORATED
: STIFEL RAISES TARGET PRICE TO $350 FROM $332
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like